Form 4: IonQ CFO Sells $2.7M in Shares Under Pre-Arranged Plan
Insider Transaction Report
IonQ's Chief Financial Officer, Thomas G. Kramer, sold 64,578 shares of common stock for a weighted average price of $41.8232 per share, totaling approximately $2.7 million, pursuant to a Rule 10b5-1 trading plan.
Summary
- Thomas G. Kramer, Chief Financial Officer of IonQ, Inc. (IONQ), disposed of 64,578 shares of common stock.
- The transaction occurred on September 3, 2025, and was executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.
- The shares were sold at a weighted average price of $41.8232 per share, with individual transaction prices ranging from $40.59 to $42.98.
- The total value of the shares sold is approximately $2,699,999.99.
- Following this transaction, Mr. Kramer directly beneficially owns 473,302 shares of common stock and indirectly owns 5 shares through a child.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a factual disclosure of a pre-planned insider stock sale under a Rule 10b5-1 plan, which is a routine event for executives managing their personal portfolios. While insider selling can sometimes be viewed negatively, the pre-arranged nature mitigates immediate concerns about company performance.
Positives
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and non-discretionary sale, which enhances transparency and mitigates concerns about insider trading based on material non-public information.
Negatives
- The sale by a key executive, the Chief Financial Officer, reduces the direct insider ownership stake in the company.
- A significant sale of approximately $2.7 million by an insider, even if pre-planned, could be perceived negatively by some investors, potentially impacting market sentiment.
Risks
- Market perception of insider selling, even under a 10b5-1 plan, could lead to short-term negative sentiment or misinterpretation by investors regarding management's confidence in the company's future prospects.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction is a routine disclosure for a publicly traded company and does not inherently reflect broader industry trends or competitive positioning. It pertains to an individual executive's personal financial planning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | The transaction was executed under a Rule 10b5-1 trading plan adopted on March 14, 2025, demonstrating adherence to corporate governance best practices for insider stock transactions. | March 14, 2025 | Enhances transparency and provides an affirmative defense against claims of insider trading, aligning executive stock sales with regulatory compliance. |
Related Party Transactions
- Thomas G. Kramer indirectly beneficially owns 5 shares of common stock through a child.
Stakeholder Impact
- Shareholders may observe the reduction in direct insider ownership, which could lead to varied interpretations regarding management's long-term commitment or personal financial strategy.
Key Dates
| Date | Description |
|---|---|
| March 14, 2025 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| September 3, 2025 | Date of the reported transaction (sale of common stock). |
| September 5, 2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThe filing details a pre-planned insider stock sale by the CFO under a Rule 10b5-1 plan. While a significant sale, its pre-arranged nature suggests it's part of personal financial management rather than a signal of new, adverse company developments. A single Form 4, especially one under a 10b5-1 plan, typically does not alter the fundamental investment thesis for a company. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position and consider this transaction in the broader context of the company's performance and market conditions.
Keywords
IonQ, IONQ, insider trading, Form 4, stock sale, CFO, Thomas G. Kramer, 10b5-1 plan, quantum computing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.